Biopharma Daily Stock Updates - 03/31/21

$XBI $135.65 +4%

---

Pipeline Updates

$BTAI -3% Ph 1b/2 data. source

$AVXL +6% Interim DSMB recommendation to continue ph 2b/3 study. source

$CTIC -2% Completes rolling NDA for pacritinib for myelofibrosis. source

$SNDX +7% Orphan Drug granted. source

$EXEL +3% EU approval of Cabometyx + Opdivo. source

Finance Updates

$ CTIC -2% Offering. source